FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3044673531> ?p ?o ?g. }

• W3044673531 endingPage "417" @default.
• W3044673531 startingPage "406" @default.
• W3044673531 abstract "Objective: To investigate the pharmacokinetics and pharmacodynamics of an ε-aminocaproic acid (EACA) regimen designed for cardiac surgery with cardiopulmonary bypass (CPB). Design: Prospective observational study requiring blood sampling to measure EACA concentrations and fibrinolysis markers (fibrinogen, D-dimer, α2-antiplasmin, and tissue plasminogen activator-plasminogen activator inhibitor [tPA-PAI-1] complex). Setting: Single-center, tertiary medical center. Participants: Patients who underwent cardiac surgery with CPB between 2018 and 2019 for aortic or mitral valve replacement/repair or coronary artery bypass grafting. Previous sternotomy patients were included. Intervention: None. Measurements and Main Results: The pharmacokinetics of EACA, during CPB, were described by a 3-compartment disposition model. EACA concentrations were greater than 130 mg/L in all patients after CPB and in most patients during CPB. The D-dimer level trended up and reached a peak median level of 1.35 mg/L of fibrinogen equivalence units (FEU) at 15 minutes after protamine administration. The median change in D-dimer (ΔD-dimer) from baseline to 15 minutes after protamine was 0.34 (–0.48 to 3.81) mg/L FEU. ΔD-dimer did not correlate with EACA concentration intraoperatively, urine output, body weight, glomerular filtration rate, cell salvage volume, and ultrafiltration volume. The median 24-hour chest tube output was 445 (180-1,011) mL. Conclusion: This regimen provided maximum EACA concentrations near the time of protamine administration, with a total perioperative dose of 15 g. Most patients had EACA concentrations greater than the target during CPB. ΔD-dimer did not correlate with EACA concentration. The median 24-hour chest tube output compared well to similar studies that used higher doses of EACA. Objective: To investigate the pharmacokinetics and pharmacodynamics of an ε-aminocaproic acid (EACA) regimen designed for cardiac surgery with cardiopulmonary bypass (CPB). Design: Prospective observational study requiring blood sampling to measure EACA concentrations and fibrinolysis markers (fibrinogen, D-dimer, α2-antiplasmin, and tissue plasminogen activator-plasminogen activator inhibitor [tPA-PAI-1] complex). Setting: Single-center, tertiary medical center. Participants: Patients who underwent cardiac surgery with CPB between 2018 and 2019 for aortic or mitral valve replacement/repair or coronary artery bypass grafting. Previous sternotomy patients were included. Intervention: None. Measurements and Main Results: The pharmacokinetics of EACA, during CPB, were described by a 3-compartment disposition model. EACA concentrations were greater than 130 mg/L in all patients after CPB and in most patients during CPB. The D-dimer level trended up and reached a peak median level of 1.35 mg/L of fibrinogen equivalence units (FEU) at 15 minutes after protamine administration. The median change in D-dimer (ΔD-dimer) from baseline to 15 minutes after protamine was 0.34 (–0.48 to 3.81) mg/L FEU. ΔD-dimer did not correlate with EACA concentration intraoperatively, urine output, body weight, glomerular filtration rate, cell salvage volume, and ultrafiltration volume. The median 24-hour chest tube output was 445 (180-1,011) mL. Conclusion: This regimen provided maximum EACA concentrations near the time of protamine administration, with a total perioperative dose of 15 g. Most patients had EACA concentrations greater than the target during CPB. ΔD-dimer did not correlate with EACA concentration. The median 24-hour chest tube output compared well to similar studies that used higher doses of EACA." @default.
• W3044673531 created "2020-07-29" @default.
• W3044673531 creator A5008806595 @default.
• W3044673531 creator A5017542783 @default.
• W3044673531 creator A5030670607 @default.
• W3044673531 creator A5038348270 @default.
• W3044673531 creator A5048167745 @default.
• W3044673531 creator A5056567386 @default.
• W3044673531 creator A5074323394 @default.
• W3044673531 creator A5083885025 @default.
• W3044673531 creator A5086949606 @default.
• W3044673531 creator A5089187341 @default.
• W3044673531 creator A5090467671 @default.
• W3044673531 date "2021-02-01" @default.
• W3044673531 modified "2023-10-06" @default.
• W3044673531 title "A Pharmacokinetic and Pharmacodynamic Investigation of an ε-Aminocaproic Acid Regimen Designed for Cardiac Surgery With Cardiopulmonary Bypass" @default.
• W3044673531 cites W148514572 @default.
• W3044673531 cites W1599132736 @default.
• W3044673531 cites W1637599331 @default.
• W3044673531 cites W1909684420 @default.
• W3044673531 cites W1965338742 @default.
• W3044673531 cites W1966392136 @default.
• W3044673531 cites W1970454941 @default.
• W3044673531 cites W1980471049 @default.
• W3044673531 cites W1982336013 @default.
• W3044673531 cites W1986213489 @default.
• W3044673531 cites W1986837360 @default.
• W3044673531 cites W1991597623 @default.
• W3044673531 cites W1993653149 @default.
• W3044673531 cites W1998362943 @default.
• W3044673531 cites W1999223726 @default.
• W3044673531 cites W2013172045 @default.
• W3044673531 cites W2015518970 @default.
• W3044673531 cites W2019598380 @default.
• W3044673531 cites W2035782714 @default.
• W3044673531 cites W2039430687 @default.
• W3044673531 cites W2039432306 @default.
• W3044673531 cites W2042229685 @default.
• W3044673531 cites W2045691857 @default.
• W3044673531 cites W2051052292 @default.
• W3044673531 cites W2056881997 @default.
• W3044673531 cites W2066288996 @default.
• W3044673531 cites W2066870497 @default.
• W3044673531 cites W2073820477 @default.
• W3044673531 cites W2079731553 @default.
• W3044673531 cites W2083309824 @default.
• W3044673531 cites W2088592005 @default.
• W3044673531 cites W2107522704 @default.
• W3044673531 cites W2111548427 @default.
• W3044673531 cites W2124649734 @default.
• W3044673531 cites W2130325689 @default.
• W3044673531 cites W2130643869 @default.
• W3044673531 cites W2148302768 @default.
• W3044673531 cites W2154062912 @default.
• W3044673531 cites W2155007797 @default.
• W3044673531 cites W2161902285 @default.
• W3044673531 cites W2185654166 @default.
• W3044673531 cites W2268592540 @default.
• W3044673531 cites W2292512830 @default.
• W3044673531 cites W2306831224 @default.
• W3044673531 cites W2406020410 @default.
• W3044673531 cites W2539290297 @default.
• W3044673531 cites W2765204564 @default.
• W3044673531 cites W2887860263 @default.
• W3044673531 cites W2919505584 @default.
• W3044673531 cites W2921240473 @default.
• W3044673531 cites W2982031101 @default.
• W3044673531 cites W30189465 @default.
• W3044673531 cites W4237091147 @default.
• W3044673531 cites W6972160 @default.
• W3044673531 doi "https://doi.org/10.1053/j.jvca.2020.07.048" @default.
• W3044673531 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32811752" @default.
• W3044673531 hasPublicationYear "2021" @default.
• W3044673531 type Work @default.
• W3044673531 sameAs 3044673531 @default.
• W3044673531 citedByCount "7" @default.
• W3044673531 countsByYear W30446735312021 @default.
• W3044673531 countsByYear W30446735312022 @default.
• W3044673531 countsByYear W30446735312023 @default.
• W3044673531 crossrefType "journal-article" @default.
• W3044673531 hasAuthorship W3044673531A5008806595 @default.
• W3044673531 hasAuthorship W3044673531A5017542783 @default.
• W3044673531 hasAuthorship W3044673531A5030670607 @default.
• W3044673531 hasAuthorship W3044673531A5038348270 @default.
• W3044673531 hasAuthorship W3044673531A5048167745 @default.
• W3044673531 hasAuthorship W3044673531A5056567386 @default.
• W3044673531 hasAuthorship W3044673531A5074323394 @default.
• W3044673531 hasAuthorship W3044673531A5083885025 @default.
• W3044673531 hasAuthorship W3044673531A5086949606 @default.
• W3044673531 hasAuthorship W3044673531A5089187341 @default.
• W3044673531 hasAuthorship W3044673531A5090467671 @default.
• W3044673531 hasConcept C111113717 @default.
• W3044673531 hasConcept C112705442 @default.
• W3044673531 hasConcept C126322002 @default.
• W3044673531 hasConcept C141071460 @default.
• W3044673531 hasConcept C2778881276 @default.
• W3044673531 hasConcept C31174226 @default.
• W3044673531 hasConcept C42219234 @default.

• next